SDZ NVI-085 is a compound with central nervous system stimulant effects, primarily acting through the α1-adrenergic receptor subtype; it exhibits anticataplectic and anti-stroke activities and demonstrates significant alertness-enhancing effects, making it useful for research on other types of hypersomnia.